• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

8,360
7,828
6,446
4,967
4,046

COUNTRY

3,298
1,712
1,141
1,010
984

CATEGORIES

  • 2,909
    • 17
    • 902
    • 512
    • 84
    • 805
    • 17
    • 504
    • 493
    • 747
    • 485
    • 0
    • 693
    • 142
  • 882
    • 92
    • 551
    • 507
    • 565
  • 8,220
    • 876
    • 1,107
    • 878
    • 45
  • 0
  • 47
  • 774
  • 1,420

PRICE

12,834
16,747
21,670
34,009

PUBLISHED

844
2,372
8,471
34,009

PRODUCT TYPE

24,213
7,732
1,018
383
171
146
145
109
63
29

Healthcare and Medical Devices

Healthcare consumes over 10% of GDP in most developed countries, and it has huge potential to grow in emerging economies such as India and China. But is the industry really in good health?

You can check the state of health of this multibillion dollar industry in the publications listed under Research and Markets’ Healthcare and Medical Devices category: our reports, books, and subscriptions will allow you to tap into the latest quantitative and qualitative data on every aspect of this dynamic and lucrative sector. They cover all the key sectors of healthcare including diagnostics (in vitro, imaging, screening, etc.); testing (glucose, cholesterol, infectious disease, etc.); hospitals (dialysis, equipment, information systems, etc.); medical devices (cardiovascular, orthopaedic, stents); and associated areas like the dental and veterinary industries.

Also covered comprehensively are regional, national and international profiles of healthcare systems - including public, private and partnerships – across the world, and associated issues such as obesity, population health, health insurance, etc.

Hundreds of players that are shaping today’s market are featured in our publications, including world's giants such as Johnson & Johnson, GE Healthcare, Covidien (formerly Tyco), Siemens Healthcare, Medtronic, and many more.

If you are looking for reports on Health Insurance please browse the relevant sub-category under Banking and Financial Services. Show Less
Read more

PRODUCT TITLE

IVD Procedure Volume and Pricing Analysis

IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are...

January 2013
FROM

Saudi Arabia Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

This new report provides key market data on the Saudi Arabia Drug Delivery Devices market The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment...

January 2013
FROM

Women and Health. Edition No. 2

Women and Health is a comprehensive reference that addresses health issues affecting women of all ages - from adolescence through maturity. It goes far beyond other books on this topic, which concentrate...

January 2013

Mexico Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others

Mexico Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others Summary Our new report, “Mexico Wound...

January 2013
FROM

Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

GlobalData’s new report, “Refractive Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Refractive Surgery Devices market in...

January 2013
FROM

Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary Our new report, “Cataract Surgery Devices Market Outlook in BRICS (Brazil, Russia, India,...

January 2013
FROM

Singapore Pharmaceuticals and Healthcare Report Q1 2013

BMI View Singapore will be of moderate attractiveness to investors given its small pharmaceutical market size, despite the growing demands for more pharmaceuticals and healthcare from its increasingly...

January 2013

Bahrain Pharmaceuticals and Healthcare Report Q1 2013

BMI View: We expect Bahrain’s pharmaceutical market values to grow steadily over the coming years. Key drivers will be volume-based, as the growing population increasingly requires more sophisticated...

January 2013

United States Pharmaceuticals and Healthcare Report Q1 2013

BMI View Despite assertions from some stakeholders, the re-election of Barack Obama as President of the United States is not bad news for pharmaceutical companies and medical device manufacturers, primarily...

January 2013

Ghana Pharmaceuticals and Healthcare Report Q1 2013

BMI View Ghana continues to outperform other markets in the region, and we predict strong growth throughout our 10 year forecast period. Ghana turns to imports for the majority of its pharmaceuticals...

January 2013

Czech Republic Pharmaceuticals and Healthcare Report Q1 2013

BMI View: The recent measures proposed by the Czech Republic's Ministry of Health will, in all likelihood, negatively affect the Czech pharmaceutical market. The introduction of reimbursement ceilings,...

January 2013

Greece Pharmaceuticals and Healthcare Report Q1 2013

BMI View The Greek pharmaceutical market has been characterised of late by mandated price reductions, state intervention in the trade of pharmaceutical goods, regressive revenue taxes, unpaid debts...

January 2013

South Africa Pharmaceuticals and Healthcare Report Q1 2013

BMI View Despite the Medicine Control Council (MCC)'s strong stance on refusing to grant compassionate access to an investigational drug targeting multi-drug resistant tuberculosis, in the face of...

January 2013

Belarus Pharmaceuticals and Healthcare Report Q1 2013

BMI View: We remain largely pessimistic about Belarus’s pharmaceutical market development, at least in the short term. The government remains committed to boosting domestic pharmaceutical output over...

January 2013

Vietnam Pharmaceuticals and Healthcare Report Q1 2013

BMI View Corruption will continue to affect Vietnam's pharmaceutical and healthcare business environment and potentially delay the introduction of universal healthcare coverage for its people. While...

January 2013

Russia Pharmaceuticals and Healthcare Report Q1 2013

BMI View The Russian pharmaceutical market remains a powerhouse in the Emerging Europe region. The country has by far the largest population in the region. Its resources-driven economic growth is...

January 2013

Indonesia Pharmaceuticals and Healthcare Report Q1 2013

BMI View Indonesia's new goal to establish universal healthcare coverage by 2019 rather than 2014 is more feasible given that the programme will be rolled out in phases. We continue to see universal...

January 2013

Israel Pharmaceuticals and Healthcare Report Q1 2013

Headline Expenditure Projections - Pharmaceuticals: ILS7.08bn (US$1.98bn) in 2011 to ILS7.44bn (US$1.89bn) in 2012; +5.1% in local currency terms and -4.8% in US dollar terms. Forecast slightly lower...

January 2013
Drug Stability for Pharmaceutical Scientists Drug Stability for Pharmaceutical Scientists - Product Thumbnail Image

Drug Stability for Pharmaceutical Scientists

Drug Stability for Pharmaceutical Scientists is a clear and easy-to-follow guide on drug degradation in pharmaceutical formulation. This book features valuable content on both aqueous and solid drug...

January 2013
Healthcare and Pharmaceuticals Report Greece Healthcare and Pharmaceuticals Report Greece - Product Thumbnail Image

Healthcare and Pharmaceuticals Report Greece

Five-year forecast Funding sources Private health insurance Industry List: Disease trends, Healthcare, Healthcare, Healthcare, Pharma &amp, biotech, Pharmaceuticals &amp, bio-tech, Healthcare,...

January 2013
Loading Indicator

Our Clients

Our clients' logos